| Literature DB >> 32612430 |
Aycan Yuksel1, Dilek Karadogan2, Canan Gunduz Gurkan3, Fatma Tokgoz Akyil4, Zehra Nur Toreyin5, Feride Marim6, Huseyin Arikan7, Tugba Sismanlar Eyuboglu8, Nagehan Emiralioglu9, Irem Serifoglu10, Elif Develi11, Selman Celik12, Umran Ozden Sertcelik13, Tugba Ramasli Gursoy8, Mehmet Fatih Elversli14, Asli Oncel13, Berrin Er15, Ali Firincioglulari16, Fatma Esra Gunaydin17, Hilal Ozakinci18, Neslihan Ozcelik2, Dorina Esendagli19, Asena Aydin20, Neslihan Kose21, Merve Ercelik22, Pinar Yildiz Gulhan22, Ethem Yildiz23, Ilim Irmak13, Bilge Yilmaz Kara2, Selcuk Gurz24, Fatma Gulsum Karakas25, Metin Akgun26.
Abstract
Scientists from all over the world have been intensively working to discover different aspects of Coronavirus disease 2019 (COVID-19) since the first cluster of cases was reported in China. Herein, we aimed to investigate unclear issues related to transmission and pathogenesis of disease as well as accuracy of diagnostic tests and treatment modalities. A literature search on PubMed, Ovid, and EMBASE databases was conducted, and articles pertinent to identified search terms were extracted. A snow-ball search strategy was followed in order to retrieve additional relevant articles. It was reported that viral spread may occur during the asymptomatic phase of infection, and viral load was suggested to be a useful marker to assess disease severity. In contrast to immune response against viral infections, cytotoxic T lymphocytes decline in SARS-CoV-2 infection, which can be partially explained by direct invasion of T lymphocytes or apoptosis activated by SARS-CoV-2. Dysregulation of the urokinase pathway, cleavage of the SARS-CoV-2 Spike protein by FXa and FIIa, and consumption coagulopathy were the proposed mechanisms of the coagulation dysfunction in COVID-19. False-negative rates of reverse transcriptase polymerase chain reaction varied between 3% and 41% across studies. The probability of the positive test was proposed to decrease with the number of days past from symptom onset. Safety issues related to infection spread limit the use of high flow nasal oxygen (HFNO) and continuous positive airway pressure (CPAP) in hypoxic patients. Further studies are required to elucidate the challenging issues, thus enhancing the management of COVID-19 patients. ©Copyright 2020 by the Atatürk University School of Medicine - Available online at www.eurasianjmed.com.Entities:
Keywords: Coronavirus; pathogenesis; transmission; venous thromboembolism
Year: 2020 PMID: 32612430 PMCID: PMC7311136 DOI: 10.5152/eurasianjmed.2020.20092
Source DB: PubMed Journal: Eurasian J Med ISSN: 1308-8734